Clinical Trial Update: Single and Multiple Ascending Doses of NTX-253 in Healthy Participants and Participants With Stable Schizophrenia [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating single and multiple ascending doses of NTX-253 in healthy participants and in individuals with stable schizophrenia. The trial is curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• NTX-253

Snippet

Sponsor: Neurosterix | Conditions: Healthy Participants, Schizophrenia Diagnosis | EARLY_Phase 1 | Status: RECRUITING